NEW YORK (GenomeWeb) – CareDx reported after the close of the market on Thursday that its third quarter revenues rose 74 percent year over year, thanks largely to a 105 percent increase in testing services revenues.

For the three months ended Sept. 30, the diagnostics company said revenues rose to $21.2 million from $12.2 million in Q3 2017, beating analysts' average estimate of $18.5 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.